Skip to main content

Table 2 Details of analysis sample, by clinical outcome

From: Clinical outcomes of a large-scale, partnership-based regional food prescription program: results of a quasi-experimental study

 

HbA1c

BMI

LDL

Systolic blood pressure

Diastolic blood pressure

n of patients available for analysis

746

857

224

508

507

n (%) in exposed group

389 (52%)

342 (40%)

112 (50%)

213 (42%)

213 (42%)

Average number of visits among exposed

5.7

4.9

8.9

5.9

5.9

Visits per month among exposed

0.93 (0.8)

1.07 (1.5)

1.14 (1.6)

1.47 (1.9)

1.47 (1.9)

Baseline mean of outcome (full sample)

8.6 (0.3)

39.9 (5.4)

88.3 (1.0)

134.5 (5.6)

79.2 (2.5)

Difference across exposed and control groups

− 0.17 (0.12)

0.14 (0.37)

-1.3 (1.1)

2.4 (1.6)

0.79 (1.6)

p for difference

0.149

0.711

0.79

0.137

0.5

Odds of visiting a food pantry for a unit increase in outcome level (OR, 95% confidence interval)

0.960 (0.911–1.005)

1.001 (0.993–1.009)

0.99 (0.999–0.999)

1.005 (0.998–1.012)

1.007 (0.985–1.030)

p for odds

0.08

0.79

0.79

0.15

0.51

β for number of visits per unit increase in outcome level

− 0.08

− 0.018

− 0.009

− 0.004

− 0.02

p for change in number of visits

0.312

0.1

0.252

0.357

0.337

Average length of pre-post period (full sample)

172

126

202

115

117

Difference across exposed and control groups

19.90

8.89

-0.74

54.86

54.90

p for difference

0.453

0.549

0.888

0.00

0.00

  1. Exposed refers to patients that visited a pantry to redeem their prescription at least once between their first and second clinical measurements; the control group is limited to patients who did not redeem their food prescription at any time between the first and second visits
  2. HbA1c glycosylated hemoglobin, BMI body mass index, LDL low density lipoprotein